z-logo
open-access-imgOpen Access
Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE
Author(s) -
Alexandros Lazaris,
David C. Coleman,
Angela Kearns,
Bruno Pichon,
Peter M. Kinnevey,
Megan R. Earls,
Breida Boyle,
Brian O’Connell,
Gráinne I. Brennan,
Anna C. Shore
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx292
Subject(s) - linezolid , enterococcus faecium , staphylococcus epidermidis , microbiology and biotechnology , outbreak , medicine , vancomycin resistant enterococcus , enterococcus , vancomycin , methicillin resistant staphylococcus aureus , biology , staphylococcus aureus , virology , antibiotics , bacteria , genetics
Linezolid is often the drug of last resort to treat infections caused by Gram-positive cocci. Linezolid resistance can be mutational (23S rRNA or L-protein) or, less commonly, acquired [predominantly cfr, conferring resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A compounds (PhLOPSA) or optrA, encoding oxazolidinone and phenicol resistance].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom